Click it and Unblock the Notifications
Just In
Don't Miss
-
IPL 2024: Arun Jaitley Stadium Pitch Report, Weather Forecast, T20, Indian Premier League Records & Stats -
Karnataka SSLC Result 2024 Soon, Know How to Check Through Website, SMS and Digilocker -
Masaba Gupta Expecting First Child With Hubby Satyadeep Misra; Neena Gupta Shares Excitement In VIRAL Post -
7:1 Bonus, Rs 778.75/Sh Dividend In 20 Yrs: Infosys To Offer Massive Rewards, Up Next Rs 28/Sh Payout Soon -
7 Questions You Should Ask Your Partner Before Getting Into An Arranged Marriage -
Nothing Ear, Ear a With ANC, Up to 42.5 Hours of Battery Launched; Check Price and Availability -
All About Electronic Stability Control ESC: Working & Advantages -
Telangana's Waterfall: A Serene Escape Into Nature's Marvels
COVID-19: Antibody cocktail treatment begins at Delhi's Sir Ganga Ram Hospital
New Delhi, June 01: The Sir Ganga Ram Hospital on Tuesday started administering monoclonal antibody cocktail (MAC) to coronavirus patients, the medical facility said in a statement.
The hospital is administering a combination of casirivimab and imdevimab to consenting patients with mild and moderate COVID-19 symptoms at high risk of developing serious illness, it added.
The MRP of one MAC dose for a patient is Rs 59,750, the statement said.
According to the Drug Controller General of India (DCGI), selection of patients will entail that they have Covid positive test report, mild to moderate Covid disease, are in the age group of 12 and above and weighing at least 40 kg, and are at high risk of COVID-19.
Dr DS Rana, Chairman (BOM), Sir Ganga Ram Hospital said, "As per the claims of the company Roche/ Cipla, we hope MAC will be a major factor in the fight against COVID-19 to prevent disease from progressing to further severity."
